If you have received a triaged grant notification from NIH — that email informing you that your application was not discussed in the study section meeting because it fell in the lower half of scores — you probably experienced a combination of confusion and frustration. You spent months on the application. You believed in your science. And now you have nothing to respond to, no feedback to act on, and a two-year setback on your research timeline.
Here is the most important thing I can tell you: triage is not random, and it is not a judgment on the quality of your science. NIH triage happens for predictable, structural reasons — reasons that are almost always fixable before the next submission cycle. After analyzing more than 200 Summary Statements across NCI, NIDDK, and NHLBI study sections, the patterns are clear.
What Triage Actually Means
In the NIH review system, approximately 50% of applications are triaged — designated as "not discussed" — before the study section meeting begins. The three assigned reviewers for your application each score it independently. If none of the three scores falls in the top half of all applications being reviewed that cycle, the application is triaged without being discussed in the full meeting.
This means triage is a pre-meeting decision by three people, not a full panel deliberation. It also means that the triage decision is often made within the first hour of a reviewer reading your application — before they have read the Approach section, before they have evaluated your methods, and often before they have read anything beyond your Specific Aims page and the opening paragraphs of your Significance section.
Reviewers form their triage-or-score decision remarkably early. The Specific Aims page and the first two paragraphs of Significance determine the trajectory of most reviews — positively or negatively.
With that context, let us look at the five most common triage triggers and how to fix each one.
Triage Reason 1: The Problem Is Not Clearly Established
The most common single reason for triage is a Significance section that fails to establish the problem compellingly before proposing a solution. Many researchers open their grant with their proposed intervention rather than with the problem the intervention solves. Reviewers need to feel the weight of the unmet need before they can appreciate your solution.
A triaged Significance section often reads: "We propose to develop a novel nanoparticle delivery system for targeted drug delivery in pancreatic cancer..." The reviewer's first reaction is: "Why this problem? What is wrong with current delivery systems? Who is dying because of this gap?"
The fix: Open your Significance section with the burden of disease, current standard of care, and its limitations — in that order. Quantify the problem with current statistics. Only introduce your proposed approach after the reviewer has been convinced the problem is real, serious, and currently unsolved. A useful structure: (1) The disease burden and current standard of care, (2) Specific limitations of current approaches, (3) The critical gap your work addresses, (4) Why addressing this gap matters clinically and scientifically.
Triage Reason 2: The Innovation Claim Is Not Credible
Reviewers are scientists. They have spent careers in your field. When your Innovation section claims that your approach is "novel," "innovative," or "unprecedented" without specific evidence, they do not believe it — and they become suspicious that you have not done a thorough literature review.
The phrase "to our knowledge, no prior studies have..." is a particularly dangerous formulation. Reviewers translate this as: "We did not find any prior studies, but we may not have looked hard enough." It signals uncertainty rather than confidence.
The fix: Instead of claiming novelty, prove it by comparison. Name the specific existing approaches and explain precisely why yours is different. For example: "Current approaches [A, B, C] share the limitation of [X]. Our approach differs in three specific ways: [1], [2], [3], which we demonstrate in [preliminary data]." This structure shows the reviewer that you know the field thoroughly and can articulate your contribution precisely.
Triage Reason 3: The Hypothesis Is Unstated or Too Broad
NIH reviewers are trained to look for a testable, falsifiable central hypothesis. When applications lack a clearly stated hypothesis — or state one that is so broad it could never be falsified — reviewers mark it as a conceptual weakness in Significance and Innovation simultaneously.
Common hypothesis errors include: (1) Restating the aims as the hypothesis ("We hypothesize that our platform will be successful"), (2) A hypothesis that is a foregone conclusion ("We hypothesize that our drug will have some effect on tumor growth"), (3) No stated hypothesis at all — just a list of things you plan to do.
The fix: Your central hypothesis should be a single, specific, falsifiable statement. It should be in the Specific Aims page and reinforced in the Significance section. A well-formed hypothesis identifies the specific mechanism, predicts a direction of effect, and can be answered by the experiments you propose. Example: "We hypothesize that [targeted inhibition of pathway X in [specific cell type]] will [reduce tumor growth] through [specific mechanism], as demonstrated by [preliminary finding]."
Triage Reason 4: The Approach Lacks Alternative Strategies
Reviewers in NIH study sections are trained to find weaknesses in experimental design. When an Approach section presents a single path through the experimental plan without acknowledging potential obstacles or alternatives, reviewers interpret this as either naivety or overconfidence — neither of which builds the trust needed for a competitive score.
The most common version of this error: an Approach section that reads like a protocol rather than a scientific strategy. Each aim is laid out as a series of steps to execute, with no discussion of what happens if a step does not work as expected.
The fix: For each major aim, include a brief "Potential Problems and Alternative Approaches" section. Identify the two or three most plausible failure modes for your key experiments and explain what you will do if they occur. This shows reviewers that you have thought deeply about the science, that you are not proceeding on blind faith, and that the research will succeed even if individual experiments require modification.
Triage Reason 5: The Specific Aims Page Does Not Set a Competitive Tone
This is the most impactful single fix available to most applicants. The Specific Aims page is the first thing reviewers read. It is often the only page they read before scoring an application for the pre-meeting discussion. A weak Specific Aims page cannot be saved by a strong Approach section — reviewers often do not get that far.
A weak Specific Aims page has: a vague opening paragraph that buries the lead, aims that read as tasks rather than scientific questions, a hypothesis that appears only at the end or not at all, and a lack of connection between the significance of the problem and the specific experiments proposed.
The fix: Structure your Specific Aims page with a sharp, concrete opening sentence that states the problem and its impact. Follow with the gap, your approach, your central hypothesis, and a brief statement of your qualifications. Aim descriptions should be active scientific questions, not passive task lists. The page should be readable in 5 minutes and leave the reviewer with a clear, compelling picture of what you are doing, why it matters, and why you are the right team to do it.
One More Thing: The Resubmission Advantage
If your grant was triaged, you have an important resource that first-time applicants do not: you know that the application was not competitive, and you can assume that the three reviewers who read it encountered one or more of the problems above. For a resubmission (A1 application), you have the opportunity to address these structural issues directly.
The Introduction to Resubmission section — required for A1 applications — is one of the most powerful sections in a grant application because it demonstrates that you have listened, thought carefully, and responded substantively. Reviewers who see a well-written Introduction to Resubmission often approach the rest of the application more generously.
If you did not receive a Summary Statement (because the application was triaged, Summary Statements are not always provided), contact your NIH Program Officer. They can often provide informal feedback on why the application did not score, which gives you the information you need for a stronger resubmission.
Let Us Write Your Next Submission
FrankGrant's Study Section simulation catches each of these triage triggers before you submit. We write your application, simulate peer review, and certify it before delivery. Starts at $2,500 for SBIR Phase I.
Hire Us to Write Your Grant →